2BB score and signals
Eikon Therapeutics Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 69 | High |
| Momentum | 57 | Stable |
| Financial strength | 41 | Normal |
| Quality | 98 | Very Strong |
| Risk | 64 | High |
Eikon Therapeutics Inc. (EIKN) Stock Score & Signals
Eikon Therapeutics Inc. (EIKN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry. Its current 2BB score is 57 out of 100.
Company facts
| Headquarters | Millbrae, California, United States |
| Founded | 2019 |
| Employees | 384 |
| P/E ratio | 0.13 |
| 52-week range | $6.45 – $17.40 |